2016
DOI: 10.1002/ps.4235
|View full text |Cite
|
Sign up to set email alerts
|

The potential of coumatetralyl enhanced by cholecalciferol in the control of anticoagulant-resistant Norway rats (Rattus norvegicus)

Abstract: The combination of coumatetralyl and cholecalciferol is a promising alternative approach to the most potent second-generation anticoagulants in resistance management, particularly in respect of environmental risks, such as secondary poisoning. © 2016 Society of Chemical Industry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 28 publications
0
8
0
1
Order By: Relevance
“…Especially interesting from the ecotoxicological aspect is the use of rodenticides with ecofriendly compounds (Kocher & Navjot, 2013;Singla et al, 2015). Endepols et. al (2017) found that a combination of vitamin D3+coumatetralyl was eff ective in controlling Tyr139Cys carriers of Rattus norvegicus.…”
Section: A New Initiative For Anticoagulant Resistancementioning
confidence: 99%
“…Especially interesting from the ecotoxicological aspect is the use of rodenticides with ecofriendly compounds (Kocher & Navjot, 2013;Singla et al, 2015). Endepols et. al (2017) found that a combination of vitamin D3+coumatetralyl was eff ective in controlling Tyr139Cys carriers of Rattus norvegicus.…”
Section: A New Initiative For Anticoagulant Resistancementioning
confidence: 99%
“…在鼠类中杀鼠灵的代谢被认 为与 P450 基因家族中的 CYP2C, CYP2B, CYP1A 和 CYP3A 亚家族中的某些基因相关 [45] . Ishizuka 等人 [46] 发 现 , [50] .…”
Section: 耐药性都是由其特定的遗传和生理基础决定的unclassified
“…To mitigate such environmental risks, in several countries the more-potent anticoagulant rodenticides are only allowed to use in or nearby invaded buildings and only after there is proof of resistance to less-potent anticoagulants. Although both combination with other drugs (for instance, coumatetralyl and cholecalciferol) 8 and proposed novel brodifacoum-like compounds computationally predicted with higher binding affinities to the main target enzyme 9 have been previously reported, there is an urgent need for new anticoagulant rodenticides and/or combinations which could maximize on-target and minimize off-target effects. Alternatively, other rodent-specific targets may also be investigated, but those are unknown.…”
Section: Introductionmentioning
confidence: 99%